Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prepepsin, the Improvement of the Early Inflammatory Biomarkers Strategy for the Diagnostics of Sepsis in Critically Ill Patients

NCT03584594 is registered in ClinicalTrials.gov with University Hospital Ostrava as lead sponsor.

NCT NCT03584594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03584594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prepepsin, the Improvement of the Early Inflammatory Biomarkers Strategy for the Diagnostics of Sepsis in Critically Ill Patients
Lead sponsor
University Hospital Ostrava
Phase
Observational
Overall status
Completed
Start date
June 1, 2018
Completion date
March 30, 2022
Enrollment
200 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

infection, sepsis